We are live on ! Find out more
AG

Algert Global Portfolio holdings

AUM $6.65B
1-Year Est. Return 53.68%
This Fund
S&P 500
This Quarter Est. Return
+5.52%
1 Year Est. Return
+53.68%
3 Year Est. Return
+140.8%
5 Year Est. Return
+204.57%
10 Year Est. Return
+1,528.09%
AUM
$4.25B
AUM Growth
+$531M
Cap. Flow
+$516M
Cap. Flow %
12.13%
Top 10 Hldgs %
5.59%
Holding
1,380
New
228
Increased
589
Reduced
316
Closed
227

Top Sells

Rank Stock Value
1
UGI icon
UGI
UGI
+$12.1M
2
CVNA icon
Carvana
CVNA
+$11.2M
3
LPX icon
Louisiana-Pacific
LPX
+$10.1M
4
PI icon
Impinj
PI
+$9.63M
5
FLEX icon
Flex
FLEX
+$9.51M

Sector Composition

Rank Sector Weight
1 Technology 16.24%
2 Financials 15.93%
3 Industrials 15.73%
4 Healthcare 13.02%
5 Consumer Discretionary 12.53%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
POWI icon
701
Power Integrations
POWI
$3.95B
$1.49M 0.04%
24,131
-6,791
-22% -$432K
NSA icon
702
National Storage Affiliates Trust
NSA
$1.49M 0.03%
39,163
-58,472
-60% -$2.51M
HEES
703
DELISTED
H&E Equipment Services
HEES
$1.48M 0.03%
30,173
-93,325
-76% -$5.08M
TGTX icon
704
TG Therapeutics
TGTX
$8.5B
$1.48M 0.03%
49,061
-55,191
-53% -$1.58M
CRNX icon
705
Crinetics Pharmaceuticals
CRNX
$8.85B
$1.47M 0.03%
28,777
-14,000
-33% -$783K
ETNB
706
DELISTED
89bio
ETNB
$1.45M 0.03%
185,407
+123,190
+198% +$1.01M
DNOW icon
707
DNOW Inc
DNOW
$2.63B
$1.45M 0.03%
111,137
+2,317
+2% +$31.2K
GEO icon
708
The GEO Group
GEO
$4.15B
$1.43M 0.03%
+51,140
New +$1.13M
PLRX icon
709
Pliant Therapeutics
PLRX
$66.9M
$1.42M 0.03%
107,603
+1,041
+1% +$14.2K
ABBV icon
710
AbbVie
ABBV
$454B
$1.41M 0.03%
7,922
+651
+9% +$120K
PRLB icon
711
Protolabs
PRLB
$1.87B
$1.4M 0.03%
35,854
-24,283
-40% -$873K
DFIN icon
712
Donnelley Financial Solutions
DFIN
$1.16B
$1.4M 0.03%
+22,336
New +$1.39M
NRC icon
713
NRC Health Common Stock
NRC
$469M
$1.4M 0.03%
79,218
-3,703
-4% -$70.2K
GMS
714
DELISTED
GMS Inc
GMS
$1.39M 0.03%
16,393
-2,594
-14% -$244K
HTLF
715
DELISTED
Heartland Financial USA, Inc.
HTLF
$1.39M 0.03%
22,679
+5,413
+31% +$339K
HLF icon
716
Herbalife
HLF
$1.22B
$1.38M 0.03%
206,009
+162,656
+375% +$1.21M
TWST icon
717
Twist Bioscience
TWST
$5.76B
$1.37M 0.03%
29,501
-14,091
-32% -$637K
NFG icon
718
National Fuel Gas
NFG
$7.8B
$1.37M 0.03%
22,514
-3,450
-13% -$211K
HAYW icon
719
Hayward Holdings
HAYW
$3.13B
$1.35M 0.03%
+88,510
New +$1.39M
CLOV icon
720
Clover Health Investments
CLOV
$2.4B
$1.35M 0.03%
428,781
+282,321
+193% +$1.01M
AOSL icon
721
Alpha and Omega Semiconductor
AOSL
$1.01B
$1.34M 0.03%
36,319
-53,601
-60% -$2M
HURN icon
722
Huron Consulting
HURN
$1.77B
$1.33M 0.03%
10,695
-5,065
-32% -$594K
OSPN icon
723
OneSpan
OSPN
$547M
$1.33M 0.03%
71,596
-129,467
-64% -$2.2M
CVGW
724
DELISTED
Calavo Growers
CVGW
$1.32M 0.03%
+51,634
New +$1.41M
CCRN
725
DELISTED
Cross Country Healthcare
CCRN
$1.31M 0.03%
72,284
+26,623
+58% +$359K

Similar funds

Algert Global's Q4 2024 Portfolio in Review

As of Q4 2024, Algert Global held 1,380 positions worth $4.25B, up 14% from $3.72B the previous quarter. Its ten largest holdings account for 5.6% of the portfolio.

Algert Global deployed $516M of net new capital in Q4 2024, opening 228 new positions and adding to 589 existing holdings. Its largest new stake was Chord Energy: 124,143 shares worth $14.5M.

By sector, the portfolio is most concentrated in Technology at 16% of assets, up from 16% a quarter earlier, followed by Financials and Industrials.

On the sell side, the largest reduction was UGI, an estimated $12.1M trimmed.

  • Algert Global's largest Q4 2024 buy was Chord Energy: 124,143 shares worth $14.5M.
  • Algert Global added most to Mueller Industries in Q4 2024, an estimated $13.4M increase.
  • Algert Global's biggest Q4 2024 reduction was UGI, cutting an estimated $12.1M.
  • Algert Global fully exited Carvana in Q4 2024, selling an estimated $11.2M.
  • Algert Global's ten largest holdings make up 5.6% of its $4.25B portfolio in Q4 2024.
  • Algert Global opened 228 new positions and closed 227 in Q4 2024.
  • Algert Global's portfolio value rose 14% quarter-over-quarter to $4.25B.

Based on Algert Global's 13F filing for Q4 2024, filed 14 Feb 2025.